- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 498/04
Total number of patents in this class: 4718
10-year publication summary
312
|
310
|
346
|
392
|
358
|
366
|
368
|
393
|
355
|
217
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
F. Hoffmann-La Roche AG | 7925 |
129 |
Genentech, Inc. | 3976 |
111 |
Merck Sharp & Dohme LLC | 3748 |
102 |
Boehringer Ingelheim International GmbH | 4650 |
91 |
Bristol-myers Squibb Company | 4898 |
85 |
Hoffmann-La Roche Inc. | 3418 |
77 |
Novartis AG | 10849 |
72 |
Rigel Pharmaceuticals, Inc. | 539 |
72 |
Gilead Sciences, Inc. | 2036 |
65 |
Takeda Pharmaceutical Company Limited | 2713 |
60 |
Amgen Inc. | 4074 |
53 |
AstraZeneca AB | 2909 |
52 |
Shionogi & Co., Ltd. | 854 |
47 |
VALO Health, Inc. | 172 |
47 |
Merck Patent GmbH | 5831 |
43 |
Janssen Pharmaceutica N.V. | 3392 |
40 |
Pfizer Inc. | 3387 |
40 |
Eli Lilly and Company | 3842 |
38 |
Merck Sharp & Dohme Corp. | 2194 |
37 |
Sumitomo Chemical Company, Limited | 9046 |
34 |
Other owners | 3423 |